SCHEMBL7757413

SCHEMBL7757413

CCCCCCCCCCCCCCCC(N)S(=O)(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.61
LAP3 P28838 2/20 0.48
SPHK1 Q9NYA1 2/20 0.47
OPRM1 P35372 1/20 0.44
S1PR2 O95136 5/20 0.44
S1PR1 P21453 5/20 0.44
S1PR3 Q99500 5/20 0.44
S1PR4 O95977 4/20 0.44
CYP2D6 P10635 2/20 0.44
GMNN O75496 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
THPO P40225 1/20 0.44
MTOR P42345 1/20 0.44
BLM P54132 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
CETP P11597 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27601220 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL27601208 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL27583707 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL28324323 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL15253464 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL27601200 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL9657415 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL5955504 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL28750757 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2
SCHEMBL27583727 1.00 TP53 (0.61) TP53LAP3SPHK1OPRM1S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100482233-C Compositions and methods for treating amyloidosis UNIV KINGSTON (CH) 2009-04-29 CN claimed
CN-1523992-A Compositions and methods for treating amyloidosis ʺ��ѧ 2004-08-25 CN claimed
CN-115530172-B Sterilization composition containing pyrimorph 中国农业大学 2024-04-05 CN disclosed
CN-101597196-B Improved drug candidate and preparation method thereof JIYAKETA CO., LTD. (CH) 2016-05-04 CN disclosed
WO-2015042020-A1 STABLE CROSS-LINKED POLYMERS LUBRIZOL ADVANCED MATERIALS, INC. (US) 2015-03-26 WO disclosed
WO-2015042028-A1 HIGH TEMPERATURE STABLE CROSS-LINKED POLYMERS THE LUBRIZOL CORPORATION (US) 2015-03-26 WO disclosed
CN-101597196-A Improved drug candidate and preparation method thereof BELLUS HEALTH INTERNAT LTD (CH) 2009-12-09 CN disclosed
CN-100528840-C Improved drug candidates and methods for their preparation NEUROCHEM INTERNAT LTD (CH) 2009-08-19 CN disclosed
CN-100482233-C Compositions and methods for treating amyloidosis UNIV KINGSTON (CH) 2009-04-29 CN disclosed
CN-1839117-A Improved drug candidates and methods for their preparation NEUROCHEM INTERNAT LTD (CH) 2006-09-27 CN disclosed
CN-1523992-A Compositions and methods for treating amyloidosis ʺ��ѧ 2004-08-25 CN disclosed
EP-0782131-B1 Magnetic recording medium TDK CORP (JP) 2001-03-28 EP disclosed
EP-0782130-B1 Magnetic recording medium TDK CORP (JP) 2000-08-09 EP disclosed
US-6063500-A MAGNETIC LAYER'S BINDER IS A BLEND OF A VINYL CHLORIDE COPOLYMER CONTAINING AMINE-MODIFIED VINYL UNITS AND ACIDIC GROUP-CONTAINING VINYL UNITS, AND POLYURETHANES HAVING SPECIFIC GLASS TRANSITION TEMPERATURES; RUNNING DURABILITY TDK CORPORATION (JP) 2000-05-16 US disclosed
US-5935714-A MAGNETIC LAYER COMPRISING MAGNETIC POWDER AND BINDER; BINDER COMPRISING MIXUTURE OF MODIFIED VINYL CHLORIDE COPOLYMER WITH AMINE AND ACIDIC FUNCTIONAL GROUPS AND POLYURETHANE RESIN; EXCELLENT RUNNING DURABILITY AND ELECTROMAGNETIC PROPERTIES TDK CORPORATION (JP) 1999-08-10 US disclosed
EP-0782130-A2 Magnetic recording medium TDK Corporation (JP) 1997-07-02 EP disclosed
EP-0782131-A2 Magnetic recording medium TDK Corporation (JP) 1997-07-02 EP disclosed